An evaluation of Ibrutinib for the treatment of Waldenstrom macroglobulinaemia
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2020.1770727
Abstract: ABSTRACT Introduction Waldenstrom Macroglobulinaemia (WM) is a heterogenous condition which poses a challenge to manage. Novel therapies such as Ibrutinib have been shown to be efficacious in treating WM. The landscape of Ibrutinib’s role in… read more here.
Keywords: ibrutinib; ibrutinib treatment; waldenstrom macroglobulinaemia; evaluation ibrutinib ... See more keywords
IgM paraprotein and anti-MAG sensory polyneuropathy associated with Waldenstrom’s macroglobulinaemia and medullary carcinoma of the thyroid
Sign Up to like & getrecommendations! Published in 2021 at "BMJ Case Reports"
DOI: 10.1136/bcr-2020-240242
Abstract: A previously fit and well 76-year-old man, presented with distal lower limb sensory symptoms suggestive of peripheral sensory neuropathy, associated with positive anti-MAG antibodies (myelin associated glycoprotein) and IgM paraprotein. Bone marrow biopsy showed lymphoplasmocytoid… read more here.
Keywords: igm paraprotein; sensory; medullary carcinoma; waldenstrom macroglobulinaemia ... See more keywords